Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3047-3059
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3047
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3047
Variable | HR (95%CI) | P for overall association | P for nonlinear association | |
Model 1 | Model 2 | |||
Age (per year increase) | 1.06 (1.03, 1.10) | 1.04 (1.01, 1.09) | 0.080 | 0.805 |
CRP (per 1 mg/L increase) | 1.15 (1.06, 1.24) | 1.10 (1.01, 1.23) | 0.062 | 0.715 |
DD (per 1 μg/mL increase of NLT | 1.89 (1.34, 2.69) | 1.63 (1.03, 2.58) | 0.012 | 0.711 |
LDH (per 10 U/L increase) | 1.06 (1.02, 1.09) | 1.04 (1.01, 1.10) | 0.080 | 0.805 |
Procalcitonin (per 1 ng/mL increase of NLT) | 2.15 (1.59, 2.90) | 1.88 (1.22, 2.88) | 0.011 | 0.721 |
- Citation: Zhao SC, Yu XQ, Lai XF, Duan R, Guo DL, Zhu Q. Dose-response relationship between risk factors and incidence of COVID-19 in 325 hospitalized patients: A multicenter retrospective cohort study. World J Clin Cases 2022; 10(10): 3047-3059
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3047.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3047